Suzhou BioBay

Technology

Last mentioned: Mar 18, 2026

Timeline

  1. Capital Pivot

    Major foreign venture funds announce new China-specific high-tech and biotech investment vehicles.

  2. Official Roadmap Launch

    China formally unveils the five-year roadmap focusing on New Quality Productive Forces.

  3. Policy Drafting

    Preliminary drafts of the 15th Five-Year Plan signal a shift toward high-tech self-reliance.

Stories mentioning Suzhou BioBay 1

pharma Bullish

Foreign Capital Pivots to China's Biotech Sector Under New Five-Year Roadmap

China's launch of its 15th Five-Year Roadmap has triggered a strategic shift in foreign investment toward high-tech sectors, with biotechnology emerging as a primary beneficiary. Global pharmaceutical giants and venture funds are recalibrating their portfolios to align with Beijing’s 'New Quality Productive Forces' initiative.

3 sources